• Home

Regulatory Requirements on Nitrosamines in the Pharmaceutical Industry Training Course: Regulatory Affairs, Sales, Quality, and Analytical Departments (ONLINE EVENT: Apr 20th – Apr 21st, 2026) – ResearchAndMarkets.com

January 15, 2026

Business Wire

GMP Auditing for Quality Assurance Training Course for FDA Regulated Industries (ONLINE EVENT) - ResearchAndMarkets.com

The “The Regulatory Requirements on Nitrosamines in the Pharmaceutical Industry Training Course (Apr 20th – Apr 21st, 2026)” training has been added to ResearchAndMarkets.com’s offering.

This course will benefit nitrosamine decision makers and those who can benefit from a broader understanding of the full picture of nitrosamines in regulatory affairs, sales, quality, and analytical departments.

Nitrosamine regulations are the most impactful change to our industry in recent years, affecting 30% of current and new products, including generics. Regulatory expectations have changed frequently and vary globally. In this webinar, we will discuss the major requirements and strategies. Those new to the subject and those growing their nitrosamine team will find value in seeing the entire picture. Experienced Small and Medium-sized Enterprises (SMEs) will receive detailed instructions for common pain points, like risk assessments.

Benefits of attending

  • Enhance your understanding of current regulatory framework and recent changes

  • See the full scope of work for your team members to understand how their part fits with the whole

  • Learn best practices for risk assessments

  • Inform next steps when your product is near or above regulatory limits through remediation, control strategies, and new research

  • Example products guide the way to practical understanding

Certification:

  • CPD: 6 hours for your records

  • Certificate of completion

Key Topics Covered:

Day 1

  • History and background

  • Classes of nitrosamines

  • Regulatory update

  • Team building

  • Risk assessments

  • At risk structures

  • Limit determination

Day 2

  • Nitrosation Assay Procedure (NAP) test

  • Analytical instruments and methods

  • Control strategy

  • Remediation

  • Post approval changes

  • Where are we going? Future state and unanswered questions

Speakers:

Jason Brown

Adare Pharma Solutions

Jason Brown brings a wealth of knowledge and practical experience to his role as Senior Analytical Sciences Manager at Adare Pharma Solutions, where he serves as the global nitrosamine subject matter expert. He has led Adare’s innovative approaches to understanding nitrosamine formation, measurement, and mitigation to ensure regulatory compliance internally and for our customers. Jason has led numerous dialogues on the subject of nitrosamines through panel discussions, webinars, posters, articles, and regular contributions to the USP Nitrosamine Forum. Jason has a BS in Chemistry from George Fox University.

For more information about this training visit https://www.researchandmarkets.com/r/vv2bgh

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260115654619/en/


Latest Press Releases

  • /C O R R E C T I O N — Elevation Point/

    January 13, 2026
  • Jazz in the Gardens Just Got Bigger: Legends Added to the 2026 Lineup

    January 13, 2026
  • 123Invent Inventor Develops the Saving Lives Shield (TKI-1259)

    January 13, 2026
  • Milestone Environmental Strengthens Permian Basin Leadership with Acquisition of Striker Slurry Injection Facility

    January 13, 2026
  • /C O R R E C T I O N — Tripadvisor/

    January 13, 2026

Latest Lifestyle

  • Ross B. Williams Announces Newly Listed Mediterranean Home at 5715 Inspiration Terrace, Bradenton FL

    January 15, 2026
  • Chhaya Anand Introduces QUAK, a Modern Interview Playbook for the AI-Driven Workforce

    January 15, 2026
  • LIXE Redefining Everyday Wear with Essential Latex Tailoring

    January 15, 2026
  • Rising R&B/Hip Hop Artist Mandu Soul Announces Debut Album, ‘Entelechy’

    January 15, 2026
  • An Inflammable Act of Kindness – Confronting Memories and Motherhood

    January 15, 2026
  • Independent Design Brand Elden Home Offers Antidote to Disposable Décor Culture

    January 15, 2026

More from NEWSnet

Top Stories

  • Language Scientific Examines Common Risks in Pharmaceutical Marketing Translation

  • Language Scientific Outlines What “Quality” Means in Medical Device Labeling Translation

  • 2026 Advanced GenAI Course Focused on Large Language Models and Diffusion Systems Launched by Interview Kickstart

  • /C O R R E C T I O N — Elevation Point/

  • Jazz in the Gardens Just Got Bigger: Legends Added to the 2026 Lineup

Latest News

  • NEW GOLD ACHIEVES 2025 PRODUCTION GUIDANCE


  • Rachel S. Lee Founder of GetFeatured.com Shares Branding and SEO Secrets to Help Entrepreneurs Transform Their Online Identity


  • Ross B. Williams Announces Newly Listed Mediterranean Home at 5715 Inspiration Terrace, Bradenton FL


  • Modexus Announces Q1 2026 Dr. Rouse Better Than Good Community Award Recipient


  • EWTN Builds One Global Catholic News Brand: Catholic News Agency and ACI Group Become EWTN News


In Case You Missed It

  • NEW GOLD ACHIEVES 2025 PRODUCTION GUIDANCE


  • Rachel S. Lee Founder of GetFeatured.com Shares Branding and SEO Secrets to Help Entrepreneurs Transform Their Online Identity


  • Ross B. Williams Announces Newly Listed Mediterranean Home at 5715 Inspiration Terrace, Bradenton FL


  • Modexus Announces Q1 2026 Dr. Rouse Better Than Good Community Award Recipient


  • EWTN Builds One Global Catholic News Brand: Catholic News Agency and ACI Group Become EWTN News


All content ©2025 Bridge News LLC
All Rights Reserved. For more information on this site, please read our Privacy Policy, Terms of Service, and Ad Choices.